As of 2024-12-15, the Relative Valuation of Axsome Therapeutics Inc (AXSM) is (156.89) USD. This relative valuation is based on P/E multiples. With the latest stock price at 90.10 USD, the upside of Axsome Therapeutics Inc based on Relative Valuation is -274.1%.
The range of the Relative Valuation is (111.27) - (174.02) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 27.1x | 24.0x |
| Forward P/E multiples | 17.3x - 27.5x | 24.9x |
| Fair Price | (111.27) - (174.02) | (156.89) |
| Upside | -223.5% - -293.1% | -274.1% |
| Date | P/E |
| 2024-12-11 | -15.23 |
| 2024-12-10 | -15.40 |
| 2024-12-09 | -15.55 |
| 2024-12-06 | -15.60 |
| 2024-12-05 | -15.33 |
| 2024-12-04 | -15.51 |
| 2024-12-03 | -15.66 |
| 2024-12-02 | -15.44 |
| 2024-11-29 | -15.31 |
| 2024-11-27 | -15.53 |
| 2024-11-26 | -15.12 |
| 2024-11-25 | -15.19 |
| 2024-11-22 | -15.38 |
| 2024-11-21 | -15.30 |
| 2024-11-20 | -14.74 |
| 2024-11-19 | -14.88 |
| 2024-11-18 | -14.41 |
| 2024-11-15 | -14.52 |
| 2024-11-14 | -15.17 |
| 2024-11-13 | -15.25 |
| 2024-11-12 | -15.50 |
| 2024-11-11 | -14.18 |
| 2024-11-08 | -14.04 |
| 2024-11-07 | -14.13 |
| 2024-11-06 | -14.18 |
| 2024-11-05 | -13.91 |
| 2024-11-04 | -13.60 |
| 2024-11-01 | -13.85 |
| 2024-10-31 | -13.87 |
| 2024-10-30 | -13.94 |
| 2024-10-29 | -14.08 |
| 2024-10-28 | -14.04 |
| 2024-10-25 | -14.01 |
| 2024-10-24 | -13.84 |
| 2024-10-23 | -14.39 |
| 2024-10-22 | -14.40 |
| 2024-10-21 | -14.26 |
| 2024-10-18 | -14.55 |
| 2024-10-17 | -14.55 |
| 2024-10-16 | -14.02 |
| 2024-10-15 | -13.47 |
| 2024-10-14 | -13.31 |
| 2024-10-11 | -13.65 |
| 2024-10-10 | -12.95 |
| 2024-10-09 | -13.02 |
| 2024-10-08 | -13.22 |
| 2024-10-07 | -13.12 |
| 2024-10-04 | -13.49 |
| 2024-10-03 | -14.21 |
| 2024-10-02 | -14.53 |